Toxicity, biodistribution, and ex vivo MRI detection of intravenously injected cationized ferritin
Open Access
- 8 May 2012
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 69 (3), 853-861
- https://doi.org/10.1002/mrm.24301
Abstract
The goal of the work was to establish the toxicity and biodistribution of the superparamagnetic protein cationized ferritin (CF) after intravenous injection. Intravenously injected CF has been used to target the extracellular matrix with high specificity in the kidney glomerulus, allowing measurements of individual glomeruli using T-weighted MRI. For the routine use of CF as an extracellular matrix-specific tracer, it is important to determine whether CF is toxic. In this work, we investigated the renal and hepatic toxicity, leukocyte count, and clearance of intravenously injected CF. Furthermore, we studied CF labeling in several organs using MRI and immunohistochemistry. Serum measurements of biomarkers suggest that intravenous injection of CF is neither nephrotoxic nor hepatotoxic and does not increase leukocyte counts in healthy rats at a dose of 5.75 mg/100 g. In addition to known glomerular labeling, confocal and MRI suggest that intravenously injected CF labels the extracellular matrix of the hepatic sinusoid, extracellular glycocalyx of alveolar endothelial cells, and macrophages in the spleen. Liver T values suggest that CF is cleared by 7 days after injection. These results suggest that CF may serve as a useful contrast agent for detection of a number of structures and functions with minimal toxicity. Magn Reson Med, 2013.Keywords
Funding Information
- American Heart Association (12BGIA9840020)
This publication has 31 references indexed in Scilit:
- Measuring glomerular number and size in perfused kidneys using MRIAmerican Journal of Physiology-Renal Physiology, 2011
- Simplified synthesis and relaxometry of magnetoferritin for magnetic resonance imagingMagnetic Resonance in Medicine, 2010
- MRI of the basement membrane using charged nanoparticles as contrast agentsMagnetic Resonance in Medicine, 2008
- Targeting of Cancer Cells with Ferrimagnetic Ferritin Cage NanoparticlesJournal of the American Chemical Society, 2006
- Liver extracellular matrix in health and diseaseThe Journal of Pathology, 2003
- Magnetoferritin: in Vitro Synthesis of a Novel Magnetic ProteinScience, 1992
- Extracellular Matrix Molecules that Influence Neural DevelopmentAnnual Review of Neuroscience, 1989
- Roles of Extracellular Matrix in Neural DevelopmentAnnual Review of Physiology, 1983
- Surface charges associated with fenestrated brain capillariesJournal of Ultrastructure Research, 1983
- Use of cationized ferritin as a label of negative charges on cell surfacesJournal of Ultrastructure Research, 1972